A Study of PRT1419 in Patients With Advanced Solid Tumors

Clinical trial NCT04837677 · COMPLETED

Trial details

NCT number: NCT04837677
Sponsor: Prelude Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sarcoma Melanoma Lung Cancer Breast Cancer Esophageal Cancer Cervical Cancer Head and Neck Cancer

Start date: 2021-08-11
Primary completion: 2023-02-06
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.